The U.S. Justice Department announced on Tuesday the indictment of Indivior Plc and a subsidiary on charges they engaged in an illegal scheme to boost prescriptions of the film version of its opioid addiction treatment Suboxone. (Source: Reuters: Health)

{ 0 comments }

Shares of Indivior Plc sank 44 percent on Wednesday after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the film version of its blockbuster opioid addiction treatment Suboxone. (Source: Reuters: Health)

{ 0 comments }

Anti-opioid addiction drug maker charged with fraud

April 11, 2019

Federal prosecutors in Virginia say the company that makes a Suboxone strips to curb opioid addiction has been lying for years about the relative safety of its product (Source: ABC News: Health)

Read the full article →

DOJ charges UK drugmaker with Suboxone fraud

April 11, 2019

Federal prosecutors with the Department of Justice have indicted Indivior for what they call a multibillion-dollar scheme to ratchet up sales of an opioid addiction treatment. (Source: PharmaManufacturing.com)

Read the full article →

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

April 11, 2019

British drugmaker Indivior Plc lost nearly three-quarters of its share value on Wednesday and former parent Reckitt Benckiser also fell following U.S. criminal charges accusing Indivior of illegally increasing prescriptions for its opioid addiction treatment Suboxone. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on […]

Read the full article →

New Buprenorphine and Naloxone Sublingual Film Indicated for The Treatment of Opioid Dependence

February 26, 2019

FDA approved Buprenorphine and Naloxone Sublingual film are available in 8 mg/2 mg and 12 mg/3 mg The prescription is limited to healthcare providers who meet certain qualifying requirements Should be used as part of a complete treatment plan to include counseling and psychosocial supportThis story is related to the following:Medicinal, Pharmaceutical& Nutraceutical Tablets (Source: […]

Read the full article →

Indivior launches generic version of its Suboxone opioid drug

February 24, 2019

British drugmaker Indivior Plc said on Wednesday it had launched a copycat version of its blockbuster opioid addiction drug Suboxone in the United States, just one day after a court decision cleared the way for its rivals to market generic versions of it. (Source: Reuters: Health)

Read the full article →

Mylan launches generic sublingual film for opioid dependence

February 24, 2019

Mylan (NSDQ:MYL) said today that it launched its buprenorphine and naloxone sublingual film as a generic of Indivior‘s (LON:INDV) Suboxone sublingual film. The product is indicated for the treatment of opioid dependence. The therapy should be used alongside counseling and psychosocial support for people living with opioid dependence, according to Mylan. Get the full story at our […]

Read the full article →

Mylan Launches Generic Suboxone(R) Sublingual Film to Treat Opioid Dependence

February 24, 2019

HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2019 — (Healthcare Sales & Marketing Network) — Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg and 12 mg/3 m… Biopharmaceuticals, Drug Delivery, Generics, Product Launch Mylan, Buprenorphine, Naloxone, Suboxone, Sublingual (Source: HSMN NewsFeed) MedWorm Message: […]

Read the full article →

U.S. top court rejects bid to block Indivior opioid drug copycat

February 20, 2019

The U.S. Supreme Court dealt a blow to Indivior Plc on Tuesday, clearing the way for a copycat version of the British pharmaceutical firm’s lucrative opioid addiction treatment Suboxone Film in a victory for India-based generic drug maker Dr. Reddy’s Laboratories. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More […]

Read the full article →